3448-97-3 Usage
Molecular structure
1H-Indole-3-acetic acid, 5-methoxy-2-methyl-1-[[4-(methylthio)phenyl]methyl]-, methyl ester is a complex organic compound with a molecular formula of C17H19NO3S.
Indole derivative
1H-Indole-3-acetic acid,
5-methoxy-2-methyl-1-[[4-(methylthio)phenyl]methyl]-, methyl ester belongs to the category of indole derivatives, which are known for their diverse biological activities and potential applications in pharmaceuticals, agrochemicals, and research.
Methyl ester
It is a methyl ester derivative of 1H-indole-3-acetic acid, which means that it has a methoxy group (-OCH3) attached to the carboxylic acid (-COOH) functional group.
Methoxy and methylthio groups
The compound contains a methoxy group (-OCH3) and a methylthio group (-SCH3), which contribute to its chemical properties and potential applications.
Phenylmethyl moiety
The compound also has a phenylmethyl group (-C6H4CH3), which is a benzene ring with a methyl group attached to a carbon atom.
Biological activity
1H-Indole-3-acetic acid, 5-methoxy-2-methyl-1-[[4-(methylthio)phenyl]methyl]-, methyl ester has potential applications in the field of pharmaceuticals due to its possible biological activity.
Precursor for synthesis
1H-Indole-3-acetic acid,
5-methoxy-2-methyl-1-[[4-(methylthio)phenyl]methyl]-, methyl ester could be used as a precursor for the synthesis of other compounds with desired properties, making it an interesting subject for further study and exploration in research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 3448-97-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,4,4 and 8 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 3448-97:
(6*3)+(5*4)+(4*4)+(3*8)+(2*9)+(1*7)=103
103 % 10 = 3
So 3448-97-3 is a valid CAS Registry Number.
3448-97-3Relevant academic research and scientific papers
N-benzyl indol-3-yl butanoic acid derivatives as cyclooxygenase inhibitors
-
, (2008/06/13)
The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. STR1 The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.
